PAPER
Functionalization of Quinolines in Positions 2 and 8
239
was stirred for 30 min, then ZnCl2 (1.5 M, 0.51 mL, 0.77 mmol)
was added and the temperature was allowed to warm to r.t. (mixture
A). In a syringe, the active catalyst was preformed from Pd(dba)2
(1 mol%, 3.45 mg, 6 µmol) and tfp (2 mol%, 2.8 mg, 12 µmol) in
THF (1 mL) and added to ethyl 4-iodobenzoate (190 mg,
0.70 mmol). To this was canulated mixture A and the reaction mix-
ture was stirred for 1.5 h at r.t. Then the mixture was quenched with
aq sat. NH4Cl solution, poured into aq NH4Cl solution (100 mL)
and extracted with EtOAc (3 × 100 mL). The combined extracts
were washed with brine (100 mL), dried (MgSO4), and concentrat-
ed under reduced pressure. Purification by flash chromatography
(pentane–EtOAc, 86:14) yielded the product 3g (307 mg, 74%) as a
white solid; mp 152 °C.
Ethyl 4-Methyl-8-(2-pyrimidinyl)-2-{[(trifluoromethyl)sulfo-
nyl]oxy}-6-quinolinecarboxylate (3i)
Compound 3i was synthesized following the typical procedure as
described for compound 3g by reacting 1a (342 mg, 0.70 mmol)
with i-PrMgCl (0.94 M, 0.82 mL, 0.77 mmol) for 10 min at –30 °C.
Following the addition of ZnCl2 (1.0 M, 0.77 mL, 0.77 mmol) the
reaction mixture was warmed to r.t. (mixture A). The catalyst was
preformed from Pd(dba)2 (6 mol%, 20.7 mg, 36 µmol) and tfp
(12 mol%, 16.8 mg, 72 µmol) in THF (1 mL) and added to 2-
iodopyrimidine11 (122 mg, 0.6 mmol). To this solution was canulat-
ed mixture A and the reaction mixture was stirred for 4 h at r.t. Then
the reaction was quenched with aq sat. NH4Cl solution and worked
up in the usual way. Purification by flash chromatography (pen-
tane–EtOAc, 86:14) yielded 3i (128 mg, 48%) as a pale yellow sol-
id; mp 151 °C.
IR (KBr): 3436 (m), 1719 (m), 1610 (w), 1416 (m), 1285 (m), 1220
(m), 1108 (m), 974 (w), 865 (w), 817 (w), 767 (w) cm–1.
IR (KBr): 3432 (m), 3072 (w), 2987 (w), 1711 (s), 1593 (m), 1569
(m), 1559 (s), 1420 (s), 1401 (s), 1300 (m), 1278 (s), 1227 (vs),
1137 (s), 1026 (w), 962 (s), 912 (w), 871 (m), 834 (m), 767 (m), 752
(m), 713 (w), 679 (m), 651 (w), 609 (m) cm–1.
1H NMR (300 MHz, CDCl3): δ = 8.93 (d, 2 H, J = 4.9 Hz, ArH-
3′,5′), 8.89 (d, 1 H, J = 1.8 Hz, ArH-7), 8.86 (d, 1 H, J = 1.8 Hz,
ArH-5), 7.37 (t, 1 H, J = 4.9 Hz, ArH-4′), 7.16–7.13 (m, 1 H, ArH-
3), 4.47 (q, 2 H, J = 7.1 Hz, CO2CH2CH3), 2.88 (d, 3 H, J = 0.9 Hz,
ArCH3), 1.44 (t, 3 H, J = 7.1 Hz, CO2CH2CH3).
1H NMR (300 MHz, CDCl3): δ = 8.80 (d, 1 H, J = 1.8 Hz, ArH-7),
8.43 (d, 1 H, J = 1.8 Hz, ArH-5), 8.16 (dm, 2 H, J = 8.4 Hz, ArH-
2′,6′), 7.75 (dm, 2 H, J = 8.4 Hz, ArH-3′,5′), 7.18–7.15 (m, 1 H,
ArH-3), 4.50 (q, 2 H, J = 7.1 Hz, ArCO2CH2CH3), 4.43 (q, 2 H,
J = 7.1 Hz, Ar′CO2CH2CH3), 2.89 (d, 3 H, J = 0.9 Hz, ArCH3), 1.47
(t, 3 H, J = 7.1 Hz, ArCO2CH2CH3), 1.44 (t, 3 H, J = 7.1 Hz,
Ar′CO2CH2CH3).
13C NMR (75 MHz, CDCl3): δ = 166.6, 165.7, 154.7, 153.2, 145.3,
142.1, 140.4, 131.2, 130.7, 129.8, 129.0, 128.9, 127.8, 126.4, 118.5
(q, JCF = 319.8 Hz), 114.1, 61.8, 61.0, 19.7, 14.3.
13C NMR (75 MHz, CDCl3): δ = 165.5, 165.3, 156.9, 155.1, 153.0,
145.7, 138.9, 131.5, 128.7, 127.8, 127.6, 119.4, 118.4 (q,
MS (EI): m/z (%) = 511 (M+, 22), 466 (29), 380 (11), 379 (44), 378
(100), 350 (40), 334 (19), 332 (15), 306 (39), 305 (12), 278 (23),
260 (18), 234 (13), 233 (10), 204 (24), 203 (11).
JCF = 321.0 Hz), 113.9, 61.8, 19.5, 14.3.
MS (EI): m/z (%) 396 ([M – OEt]+, 5), 309 (22), 308 (100), 280 (29).
HRMS: m/z calcd for C23H20F3NO7S: 511.0913; found: 511.0897.
HRMS: m/z calcd for C18H14F3N3O5S: 442.0685 [M + H]+ ; found:
442.0712 [M + H]+.
Anal. Calcd for C23H20F3NO7S (511.47): C, 54.01; H, 3.94; N, 2.74.
Found: C, 53.85; H, 3.90; N, 2.76.
Anal. Calcd for C18H14F3N3O5S (441.38): C, 48.98; H, 3.20; N,
9.52. Found: C, 49.06; H, 3.10; N, 9.36.
Ethyl 4-(4-Methyl-6-(trifluoromethyl)-2-{[(trifluoromethyl)-
sulfonyl]oxy}-8-quinolinyl)benzoate (3h)
Ethyl 8-Allyl-2-ethyl-4-methyl-6-quinolinecarboxylate (4a)
According to the typical procedure described for compound 3g, the
active catalyst was preformed from Pd(dba)2 (1 mol%, 2.9 mg, 5
µmol) and tfp (2 mol%, 2.3 mg, 10 µmol) in THF (0.7 mL) and add-
ed to 3c (202 mg, 0.50 mmol). To this mixture was canulated Et2Zn
(1.0 M in Et2O, 1.05 mL, 1.05 mmol) and the reaction mixture was
stirred for 35 min at r.t., then quenched with aq sat. NH4Cl solution.
Workup in the usual way and purification by flash chromatography
(pentane–EtOAc, 96:4) yielded the product 4a (115 mg, 82%) as a
white solid; mp 69 °C.
Compound 3h was synthesized following the typical procedure as
described for compound 3g by reacting 1b (400 mg, 0.83 mmol)
with i-PrMgCl (0.94 M, 0.97 mL, 0.91 mmol) for 40 min at –30 °C.
After the addition of ZnBr2 (1.5 M, 0.61 mL, 0.91 mmol), the reac-
tion mixture was warmed to r.t. (mixture A). The catalyst was pre-
formed from Pd(dba)2 (2 mol%, 7.9 mg, 14 µmol) and tfp (4 mol%,
6.38 mg, 28 µmol) in THF (1 mL) and added to ethyl 4-iodoben-
zoate (190 mg, 0.69 mmol). To this solution was canulated mixture
A and the reaction mixture was stirred for 3.5 h at r.t., then
quenched with aq sat. NH4Cl solution and worked up in the usual
way. Purification by flash chromatography (pentane–EtOAc, 97:3)
yielded the product 3h (221 mg, 63%) as a white solid; mp 128 °C.
IR (KBr): 3426 (w), 2977 (m), 2933 (w), 1713 (vs), 1604 (m), 1570
(w), 1497 (w), 1468 (w), 1418 (m), 1366 (w), 1271 (s), 1240 (m),
1222 (m), 1199 (m), 1144 (w), 1114 (w), 1033 (m), 995 (w), 915
(m), 904 (m), 869 (w), 766 (m), 512 (w) cm–1.
1H NMR (300 MHz, CDCl3): δ = 8.59 (d, 1 H, J = 1.8 Hz, ArH-5),
8.11 (d, 1 H, J = 1.8 Hz, ArH-7), 7.18–7.15 (m, 1 H, ArH-3), 6.29–
6.14 (m, 1 H, CH2CH=CH2), 5.24–5.16 (m, 1 H, CH2CH=CHtransH),
5.11–5.06 (m, 1 H, CH2CH=CHcisH), 4.45 (q, 2 H, J = 7.1 Hz,
CO2CH2CH3), 4.09 (d, 2 H, J = 6.6 Hz, CH2CH=CH2), 2.97 (q, 2 H,
J = 7.5 Hz, ArCH2CH3), 2.72 (d, 3 H, J = 0.9 Hz, ArCH3), 1.45 (t, 3
H, J = 7.1 Hz, CO2CH2CH3), 1.41 (t, 3 H, J = 7.5 Hz, ArCH2CH3).
IR (KBr): 3436 (m), 2987 (w), 1706 (s), 1610 (m), 1465 (m), 1418
(s), 1370 (m), 1284 (s), 1225 (s), 1132 (s), 1062 (m), 1024 (m), 976
(m), 898 (m), 865 (m), 802 (m), 766 (m), 708 (m), 653 (m), 607 (m)
cm–1.
1H NMR (300 MHz, CDCl3): δ = 8.37–8.34 (m, 1 H, ArH-7), 8.16
(d, 2 H, J = 8.8 Hz, ArH-2′,6′), 8.02 (d, 1 H, J = 1.8 Hz, ArH-5),
7.74 (d, 2 H, J = 8.8 Hz, ArH-3′,5′), 7.22 (d, 1 H, J = 0.9 Hz, ArH-
3), 4.43 (q, 2 H, J = 7.1 Hz, CO2CH2CH3), 2.88 (d, 3 H, J = 0.9 Hz,
ArCH3), 1.44 (t, 3 H, J = 7.1 Hz, CO2CH2CH3).
13C NMR (75 MHz, CDCl3): δ = 166.8, 164.5, 148.0, 145.5, 139.6,
137.6, 127.7, 126.5, 126.0, 125.0, 122.4, 115.7, 61.1, 36.0, 32.1,
19.0, 14.4, 13.1.
13C NMR (75 MHz, CDCl3): δ = 166.4, 154.7, 152.7, 141.6, 141.4,
130.7, 130.2, 130.1, 129.9 (q,
JCF = 19.4 Hz), 129.6 (q,
J
CF = 33.5Hz), 127.7, 127.3 (q, JCF = 2.9 Hz), 127.2, 121.5 (q,
MS (EI): m/z (%) = 283 (M+, 58), 282 (22), 269 (20), 268 (100), 254
(23), 241 (11), 240 (63), 238 (18), 225 (14), 210 (13), 195 (15), 180
(10).
JCF = 4.1 Hz), 118.5 (q, JCF = 321.0 Hz), 114.6, 61.1, 19.5, 14.3.
MS (EI): m/z (%) = 507 (M+, 18), 462 (16), 374 (38), 346 (43), 330
(11), 328 (17), 303 (19), 392 (100), 301 (25), 300 (11).
HRMS: m/z calcd for C18H21NO2: 283.1572; found: 283.1582.
HRMS: m/z calcd for C21H15F6NO5S: 507.0575; found: 507.0577.
Anal. Calcd for C18H21NO2 (283.36): C, 76.29; H, 7.47; N, 4.94.
Found: C, 76.29; H, 7.31; N, 4.92.
Synthesis 2003, No. 2, 233–242 ISSN 0039-7881 © Thieme Stuttgart · New York